GPCR & Membrane Protein Specific Antibodies

On this page

Detect GPCRs in research, drug discovery, diagnostics, and therapeutic development

What's inside the book?

Introduction to GPCR & Membrane Protein Antibodies

Overview of Conigen’s antibody discovery platform and applications in research, diagnostics, and therapeutics.

AI-Enabled Precision Antibody Discovery Platform

Immunogen engineering, immune-focusing strategies, and methods for breaking immune tolerance.

Integrated Workflow & Technology Platform

End-to-end process from target analysis and immunogen design to antibody screening and validation.

Why Extracellular Domain (ECD) GPCR Antibodies Matter

Importance of live-cell staining, receptor specificity, and native-state GPCR detection.

GPCR Monoclonal Antibody Portfolio

Overview of GPCR targets across cardiovascular, metabolic, immunology, neurology, oncology, and psychiatry applications.

Spotlight Antibodies & Case Studies

Featured antibodies including DRD2, PAR1, GPR52, GPR75, GLP1R, GIPR, MAS1, APLNR, CALRL, LGR4, FZD10, ADGRE2, GPR19, and P2RY13.

Other Membrane Protein Antibody Platforms

CD3-epsilon/delta, IFNαR1/R2 heterodimer, and CFTR extracellular loop antibodies.

Validation & Performance Data

ELISA, SPR affinity, and live-cell flow cytometry characterization examples.